When: Q3 miss with guidance reset OR close below $215 on volume >30M

Then: Full exit or aggressive Underweight

Trim 20-30% with protective puts instead of naked short; tighten framework with closing-price triggers at 228 and 240

• Current price 234; 50 SMA at 237.92; proposed stop at 248 is above resistance and poorly placed
• Consolidation range of 204 to 242 held for over six weeks; two 25% drawdowns occurred in February and July, not current regime
• Traders plan of 30-50% trim pulled back to 20-30%; naked short creates 2.82% annual dividend drag and unlimited upside risk
• Protective put premium capped at 1% of portfolio notional vs 2-3% carrying cost for naked short
• Q2 revenue up 1.1% year over year; 160 basis points margin compression is acquisition-related from HashiCorp, not business deterioration
• 0.71 beta measures market sensitivity, not idiosyncratic risk; 25% drawdowns were earnings-specific events, not broad market moves
• IBM trades like a bond proxy with equity optionality (2.82% dividend, 12B free cash flow), not like long-duration tech
• Sell-the-news pattern is symmetric and can resolve violently once positioning shifts
• Conservative stop framework: hard stop below 228 on closing prices; hold above 240; maintain trimmed position between 228-240
• If wrong on downside, trim captures most of it; if wrong on upside, short loses money with fixed ongoing carrying cost
• Aggressive analyst's 70% Bollinger squeeze directional bias statistic disputed; John Bollinger himself stated no directional bias

→ vs aggressive: Bollinger squeeze 70% directional bias cited by aggressive analyst is not statistically robust; John Bollinger stated squeezes have no directional bias; setup is a coin flip on direction, not 70% downside probability

→ vs aggressive: IBM does not trade like long-duration tech during rate shocks given 2.82% covered dividend, 12B free cash flow, and 0.71 beta; trades like bond proxy with equity optionality; macro headwind has been applying pressure for months and stock has not broken down from 204-242 range

→ vs aggressive: Goodwill impairment is a lagging indicator requiring sustained deterioration over multiple quarters, not a near-term catalyst; one quarter of 1.1% growth and acquisition-related margin compression is normal post-acquisition adjustment, not impairment setup

→ vs aggressive: Beta of 0.71 is not meaningless; it measures sensitivity to broad market movements, not idiosyncratic catalyst risk; February and July drawdowns were earnings shocks that would have occurred regardless of beta; 0.71 beta is most valuable during broad market selloffs

→ vs aggressive: Q3 earnings framed as 50/50 coin flip with 25% drawdown probability is wrong; market has already positioned for disappointment, sentiment is poor, and even a modest beat with stable margins could rally 8-12%; downside scenario requires major guide-down or third consecutive quarter of deterioration

→ vs aggressive: Naked short on dividend-paying stock creates 2.82% annual dividend drag paid to lender, unlimited upside risk on squeeze, and overnight gap risk that stops cannot protect against; risk-reward is worse than framed because downside on hedge is bounded but upside is bounded only by the move itself

TRIM 30% of existing IBM position; implement put spread hedge; maintain trimmed core position

• Trim 30% of existing IBM exposure at current levels around $234, between aggressive analyst's 30-50% and conservative analyst's implicit position
• Implement put spread hedge through Q3 earnings: buy put at or slightly below current price, sell put $15-20 lower; size at 1-1.5% of portfolio notional
• Use close-only stop triggers: stop on further reductions at close below $228, re-evaluation trigger on close above $240
• IBM trades at 17.78x forward earnings with PEG of 2.22, not a true bond proxy multiple; vulnerable to multiple compression
• Goodwill of $74.6 billion (49% of total assets) represents material tail risk with elevated probability given binary Q3 catalyst
• Aggressive analyst's cited 70% Bollinger Band squeeze directional bias is fabricated; John Bollinger stated squeezes have no directional bias
• Beta of 0.71 is meaningful in hawkish Fed environment as it measures market sensitivity, not idiosyncratic risk
• Consensus HOLD from technical, fundamentals, and macro reports is not wrong; IBM retains defensive characteristics, AI/quantum pipeline, and CHIPS Act tailwinds
• Maintain trimmed core for defensive characteristics, $12 billion free cash flow, and 2.82% dividend yield

→ vs aggressive: The 70% Bollinger Band squeeze directional bias statistic is fabricated; John Bollinger explicitly stated squeezes have no directional bias, undermining the downside breakout thesis

→ vs aggressive: HOLD is not the most dangerous position; an oversized directional bet with stop above resistance at $248 (6% above current, above 50 SMA at $237) forces re-entry on bounces—worse than holding

→ vs aggressive: Beta of 0.71 measures market sensitivity, not idiosyncratic risk; dismissing it based on earnings-specific drawdowns is backwards

→ vs conservative: IBM at 17.78x forward P/E with PEG of 2.22 is not a bond proxy multiple; true bond proxies trade at 10-12x with >4% yield

→ vs conservative: Goodwill impairment is not just a tail risk; $74.6B (49% of assets) creates material downside if Q3 catalyst disappoints with 10% partial impairment = $7.5B charge

→ vs conservative: Sell-the-news pattern has persisted through entire H2 2026; positioning for sharp reversal ignores that asymmetric downside has been the realized pattern